Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
MD Anderson
Mar 24, 2024, 23:53 |
Blog
Peter Pisters: I enjoyed sharing my personal learnings and reflections as I transitioned from the operating room to the board room for the SSO2024
Peter Pisters, President at MD Anderson Cancer Center, shared on LinkedIn: “Terrific day in Atlanta…
Mar 24, 2024, 13:54 |
Blog
Naveen Pemmaraju: Delighted to share my interview and discussion with Dr Neil Love on BPDCN
Naveen Pemmaraju shared on LinkedIn: "Delighted to share my interview and discussion with Dr Neil Love…
Mar 24, 2024, 00:09 |
Blog
Vivek Subbiah: Tune in to the podcast for insights into equitable access to cancer clinical trials
Vivek Subbiah posted on LinkedIn “Excited to announce my latest venture! Hosting an interview with…
Mar 23, 2024, 15:07 |
Insight
Anirban Maitra: The story of NexCAR19 from India
Anirban Maitra, Scientific Director of the Sheikh Ahmed Pancreatic Cancer Research Center at UT MD…
Mar 22, 2024, 05:19 |
Blog
Erika Hamilton: 100 cycles on a phase I clinical trial for metastatic disease - THIS is why we do clinical trials
Erika Hamilton and Vivek Subbiah shared a post by Sarah Cannon Research Institute: "Several years ago,…
Mar 21, 2024, 17:54 |
Career
ASCO announces the recipients of 2024 Special Awards
ASCO shared on their X page: "Along with Conquer Cancer Foundation, we congratulate the recipients…
Mar 21, 2024, 12:08 |
Blog
Li Ma: In genetically engineered mouse models MALAT1 protects against osteoporosis and bone metastasis
Li Ma, Professor of Experimental Radiation Oncology at MD Anderson Cancer Centre, shared on X/Twitter:…
Mar 19, 2024, 23:26 |
Blog
Naveen Pemmaraju: Thrilled to share our new high-impact paper just out in The Lancet Oncology
Naveen Pemmaraju posted on X: "Thrilled to share our new high-impact paper just out in…
Mar 19, 2024, 20:14 |
Blog
Vivek Subbiah: Nice to see CAR-T cells showing early signals of activity in Glioblastoma in a Phase 1
Vivek Subbiah shared a post on LinkedIn: "Nice to see CAR-T cells showing early signals of…
Mar 19, 2024, 03:44 |
Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
122
123
124
125
126
All:
1560
Posts:
1231 - 1240
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube